EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,256,866 | -1.0% | 2,428,490 | +114.1% | 0.03% | 0.0% |
| Q2 2023 | $8,337,987 | -14.7% | 1,134,420 | +20.2% | 0.03% | -18.4% |
| Q1 2023 | $9,776,318 | -1.1% | 943,660 | +12.7% | 0.04% | 0.0% |
| Q4 2022 | $9,889,222 | +33.7% | 837,360 | +137.5% | 0.04% | +18.8% |
| Q3 2022 | $7,399,000 | -12.4% | 352,500 | +29.6% | 0.03% | -5.9% |
| Q2 2022 | $8,445,000 | -15.4% | 272,060 | +11.8% | 0.03% | +6.2% |
| Q1 2022 | $9,988,000 | -0.2% | 243,260 | +5.7% | 0.03% | +3.2% |
| Q4 2021 | $10,008,000 | +32.2% | 230,230 | +52.2% | 0.03% | +29.2% |
| Q3 2021 | $7,572,000 | +256.8% | 151,230 | +322.5% | 0.02% | +166.7% |
| Q4 2018 | $2,122,000 | -32.2% | 35,794 | -24.7% | 0.01% | -18.2% |
| Q3 2018 | $3,130,000 | +76.1% | 47,548 | +35.1% | 0.01% | +57.1% |
| Q2 2018 | $1,777,000 | +73.0% | 35,192 | +80.4% | 0.01% | +75.0% |
| Q1 2018 | $1,027,000 | +13.4% | 19,507 | 0.0% | 0.00% | +33.3% |
| Q4 2017 | $906,000 | – | 19,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |